☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
full-life technologies
Full-Life Technologies’ 225Ac-FL-020 Gains the US FDA’s Fast Track Designation to Treat Metastatic Castration-Resistant Prostate C...
July 4, 2024
Full-Life Technologies Signed an Agreement to Acquire Focus-X Therapeutics to Advance Peptide-Focused Radiopharmaceutical Pipeline
November 29, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.